The FDA has declared that the shortage of popular weight-loss drugs, including Ozempic and Wegovy, is officially over.

When the FDA declared an Ozempic and Wegovy shortage, business boomed for pharmacies making cheaper, off-brand versions of ...

Ongoing trials of the next generation of weight loss drugs are revealing something unexpected: Some patients are losing too ...

The FDA has approved updated labeling for Sublocade (buprenorphine extended-release) injection to include a rapid induction protocol and alternative injection sites.

RAs are transforming obesity treatment, demonstrating substantial weight loss and metabolic improvements with lifestyle ...

The Indianapolis-based pharmaceutical company announced plans for four new manufacturing sites, but has not decided where ...

Consumer Reports warns there are important considerations, especially for older adults, before starting these treatments.

The number of teens and young adults taking GLP-1 drugs has increased by 594 percent—but scientists are still trying to ...

It comes as companies work to build goodwill with Trump, who has emphasized reshoring manufacturing to the U.S. and reducing ...

Eli Lilly releases cheaper vials of the weight-loss drug for self-paying patients and cuts the price of two existing doses.

A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.

(CNN) — Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug ...